TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
成佳憲Chen, Chia-Hsien
- 計畫主持人
- 執行臨床試驗年資 12 年 9 個月
發表文獻
95筆
1
Lee SU*, Yoon SM*, Cheng JC*, Kim TH, Kim BH, Park JH, Jung JH, Tsai CL, Chiang Y, Park JW. Multi-institutional retrospective study of radiotherapy for hepatocellular carcinoma in the caudate lobe. Frontiers in Oncology 11: 646473, 2021 ( (co-first author)
2
Kim N*, Cheng J*, Huang WY, Kimura T, Zeng ZC, Lee VH, Kay CS, Seong J. Dose-response relationship in stereotactic body radiation therapy for hepatocellular carcinoma: a pooled-analysis of an Asian Liver Radiation Therapy Group study. International Journal of Radiation Oncology, Biology, Physics 109:464-473, 2021 (
(co-first author)
(co-first author)
3
Lo CH, Lee HL, Hsiang CW, Chiou JF, Lee MS, Chen SW, Shen PC, Lin CS, Chang WC, Yang JF, Dai YH, Chen CY, Cheng JC*, Huang WY*. Pretreatment neutrophil-to-lymphocyte ratio predicts survival and liver toxicity in patients with hepatocellular carcinoma treated with stereotactic ablative radiotherapy. International Journal of Radiation Oncology, Biology, Physics 109:474-484, 2021 (SCI) (co-corresponding author)
4
Hsu YC, Lee HT, Wang YJ, Wang MC, Tsai CL, Wu JK, Huang TJ, Lin CW, Cheng JC*. Using mega-voltage computed tomography to estimate radiotherapy dose for high-density metallic implants. IEEE Transactions on Instrumentation and Measurement 70:1-11, 2021 (SCI)
5
Wang YJ, Yao JS, Lai FP, Cheng JC*. CT-based collision prediction software for external-beam radiation therapy. Frontiers in Oncology 11:617007, 2021 (SCI)
6
Huang TJ, Tien Y, Wu JK, Huang WT, Cheng JC*. Impact of breath-hold level on positional error aligned by stent/lipiodol in hepatobiliary radiotherapy with breath-hold respiratory control. BMC Cancer 20: 613, 2020 (SCI)
7
Chen YL, Hsu FM, Tsai JC, Cheng JC*. Efforts to reduce the impacts of COVID-19 outbreak on radiation oncology in Taiwan. Advances in Radiation Oncology 5:534-537, 2020
8
Tien Y, Tsai CL, Hou WH, Chiang Y, Hsu FM, Tsai YC, Cheng JC*. Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells. Radiation Oncology 15:58, 2020 (SCI)
9
Huang WY, Tsai CL, Que JY, Lo CH, Lin YJ, Dai YH, Yang JF, Shen PC, Lee MH*, Cheng JC*. Development and validation of a nomogram for patients with non-metastatic BCLC stage C hepatocellular carcinoma after stereotactic body radiotherapy. Liver Cancer 9: 326-337, 2020 (SCI)
10
Chiang Y, Wang CC, Tsai YC, Huang CY, Pu YS, Lin CC*, Cheng JC*. Nuclear factor-κappa B overexpression is correlated with poor outcomes after multimodality bladder-preserving therapy in patients with muscle-invasive bladder Cancer. Journal of Clinical Medicine 8:1954, 2019 (SCI)
